Skip to Main Content

More than two dozen of the largest pharmaceutical companies are urging President Biden to reject a proposal before the World Trade Organization to temporarily waive patent rights in order to widen access to Covid-19 medical products to mostly low-income countries.

In a March 5 letter, the drug makers argue that, contrary to assertions, intellectual property is not a barrier to ensuring that vaccines and therapies become available on a global basis. Along with their trade groups, the companies also maintained that eliminating intellectual property protection to allow other manufacturers to make certain products would not speed production or access.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • What is wrong with let US, EU, UK, Canada, Switzer Kaz, Norwary, and Brazil achieve herd immunity within their own borders first then worry about and tckle the rest of the world?

Comments are closed.